Noxopharm (ASX:NOX) Shares Buyback Ratio % : 0.00 (As of May. 15, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Noxopharm's current shares buyback ratio was 0.00%.

Noxopharm Shares Buyback Ratio % Historical Data

The historical data trend for Noxopharm's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Shares Buyback Ratio % Chart

Noxopharm Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-0.57

-53.57

-35.19

-1.39

Noxopharm Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Shares Buyback Ratio %	Get a 7-Day Free Trial										-1.39	-	-	-	-

Noxopharm Shares Buyback Ratio % Calculation

Noxopharm's Shares Buyback Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2022 )	-	Shares Outstanding (EOP) (A: Jun. 2023 ))	/	Shares Outstanding (EOP) (A: Jun. 2022 )
	=	(292.238	-	292.238)	/	292.238
	=	0.00%

Noxopharm's Shares Buyback Ratio for the quarter that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	(292.238	-	292.238)	/	292.238
	=	0.00%

Noxopharm Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Noxopharm's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Noxopharm (ASX:NOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

NOXOF:USA

Address

60 Linksley Ave, Glenhaven, NSW, AUS, 2156

Website

https://www.noxopharm.com

Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines